Brazil Biotechnology Market Size & Outlook, 2023-2030
Brazil biotechnology market, 2018-2030 (US$M)
Related Markets
Brazil biotechnology market highlights
- The Brazil biotechnology market generated a revenue of USD 27,347.3 million in 2023 and is expected to reach USD 69,140.3 million by 2030.
- The Brazil market is expected to grow at a CAGR of 14.2% from 2024 to 2030.
- In terms of segment, health was the largest revenue generating application in 2023.
- Bioinformatics is the most lucrative application segment registering the fastest growth during the forecast period.
Biotechnology market data book summary
| Market revenue in 2023 | USD 27,347.3 million |
| Market revenue in 2030 | USD 69,140.3 million |
| Growth rate | 14.2% (CAGR from 2023 to 2030) |
| Largest segment | Health |
| Fastest growing segment | Bioinformatics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Health, Food & Agriculture, Natural reseources & Environment, Industrial Processing, Bioinformatics, Others Applications |
| Key market players worldwide | AstraZeneca PLC, Gilead Sciences Inc, Bristol-Myers Squibb Co, Sanofi SA, Biogen Inc, Abbott Laboratories, Pfizer Inc, Amgen Inc, Novo Nordisk A/S ADR, Merck KGaA, Johnson & Johnson, Novartis AG ADR, Roche Holding AG, Lonza Group Ltd |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.8% of the global biotechnology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil biotechnology market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 69,140.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biotechnology Market Scope
Biotechnology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil biotechnology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology market will help companies and investors design strategic landscapes.
Health was the largest segment with a revenue share of 45.76% in 2023. Horizon Databook has segmented the Brazil biotechnology market based on health, food & agriculture, natural reseources & environment, industrial processing, bioinformatics, others applications covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil accounts for the largest share in Latin America biotechnology market. This can be attributed to the improving infrastructure, expansion of sequencing technologies, and increasing interest of global players in this region.
For instance, in October 2019, Veritas Intercontinental signed an agreement with genetic testing lab Genomika, based in Brazil, to offer whole-genome and exome sequencing services in this region. In addition, an increase in healthcare expenditure of Brazil (nearly 8.9%) is anticipated to further drive the market.
The presence of a natural demographic ethnic diversity in the regional population is also expected to attract R&D for DNA sequencing related diagnostic kits and therapies for certain diseases in this region. In March 2020, Brazilian scientists conducted the first genetic sequencing of SARS-CoV-2 within 48 hours.
Reasons to subscribe to Brazil biotechnology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil biotechnology market databook
-
Our clientele includes a mix of biotechnology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil biotechnology market , including forecasts for subscribers. This country databook contains high-level insights into Brazil biotechnology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil biotechnology market size, by application, 2018-2030 (US$M)
Brazil Biotechnology Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
